Sensei Biotherapeutics, Inc.
NASDAQ:SNSE
Overview | Financials
Company Name | Sensei Biotherapeutics, Inc. |
Symbol | SNSE |
Currency | USD |
Price | 0.454 |
Market Cap | 11,421,251 |
Dividend Yield | 0% |
52-week-range | 0.384 - 1.94 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. John K. Celebi M.B.A., MBA |
Website | https://www.senseibio.com |
An error occurred while fetching data.
About Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response; and Tumor Microenvironment
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD